Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

NCT03019055 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, B-Cell
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

BIOLOGICAL: CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (2.5 x10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (7.5 x10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg)

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]